Morgan Stanley Bristol Myers Squibb CO Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Morgan Stanley holds 31,938,714 shares of BMY stock, worth $1.54 Billion. This represents 0.14% of its overall portfolio holdings.

Number of Shares

31,938,714

Previous 30,339,775 5.27%

Holding current value

$1.54 Billion

Previous $1.72 Billion 13.52%

% of portfolio

0.14%

Previous 0.12%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$53.9 - $63.11 $86.2 Million - $101 Million	1,598,939 Added 5.27%	31,938,714 $1.95 Billion
Q4 2024 Feb 14, 2025	BUY	$51.92 - $59.94 $124 Million - $143 Million	2,381,163 Added 8.52%	30,339,775 $1.72 Billion
Q3 2024 May 14, 2025	BUY	$39.66 - $51.75 $71.5 Million - $93.3 Million	1,803,507 Added 6.9%	27,958,612 $1.45 Billion
Q3 2024 Nov 14, 2024	BUY	$39.66 - $51.75 $71.5 Million - $93.3 Million	1,803,507 Added 6.9%	27,958,612 $1.45 Billion
Q2 2024 May 14, 2025	SELL	$40.25 - $52.99 $168 Million - $222 Million	-4,184,670 Reduced 13.79%	26,155,105 $1.09 Billion
Q2 2024 Oct 17, 2024	SELL	$40.25 - $52.99 $125 Million - $165 Million	-3,114,505 Reduced 10.64%	26,155,105 $1.09 Billion
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $125 Million - $165 Million	-3,114,505 Reduced 10.64%	26,155,105 $1.09 Billion
Q1 2024 Oct 17, 2024	BUY	$47.98 - $54.4 $149 Million - $169 Million	3,114,505 Added 11.91%	29,269,610 $1.59 Billion
Q1 2024 Aug 16, 2024	SELL	$47.98 - $54.4 $5.37 Million - $6.09 Million	-111,861 Reduced 0.38%	29,269,610 $1.59 Billion
Q1 2024 May 15, 2024	SELL	$47.98 - $54.4 $5.37 Million - $6.09 Million	-111,861 Reduced 0.38%	29,269,610 $1.59 Billion
Q4 2023 Aug 16, 2024	BUY	$48.48 - $57.85 $156 Million - $187 Million	3,226,366 Added 12.34%	29,381,471 $1.51 Billion
Q4 2023 Feb 13, 2024	SELL	$48.48 - $57.85 $351 Million - $419 Million	-7,240,486 Reduced 19.77%	29,381,471 $1.51 Billion
Q3 2023 Nov 15, 2023	BUY	$57.89 - $64.73 $95.5 Million - $107 Million	1,649,374 Added 4.72%	36,621,957 $2.13 Billion
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $103 Million - $114 Million	1,615,948 Added 4.84%	34,972,583 $2.24 Billion
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $135 Million - $153 Million	-2,055,535 Reduced 5.8%	33,356,635 $2.31 Billion
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $400 Million - $474 Million	5,840,425 Added 19.75%	35,412,170 $2.55 Billion
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $858,105 - $507 Million	-6,600,811 Reduced 18.25%	29,571,745 $2.1 Billion
Q2 2022 Oct 27, 2022	BUY	$72.62 - $79.98 $625 Million - $688 Million	8,606,607 Added 31.22%	36,172,556 $2.79 Billion
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $625 Million - $688 Million	8,606,607 Added 31.22%	36,172,556 $2.79 Billion
Q1 2022 Oct 27, 2022	SELL	$61.48 - $73.72 $529 Million - $634 Million	-8,606,607 Reduced 23.79%	27,565,949 $2.01 Billion
Q1 2022 May 13, 2022	BUY	$61.48 - $73.72 $175 Million - $210 Million	2,850,019 Added 11.53%	27,565,949 $2.01 Billion
Q4 2021 Feb 14, 2022	SELL	$53.63 - $62.52 $20.4 Million - $23.7 Million	-379,859 Reduced 1.51%	24,715,930 $1.54 Billion
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $1.48 Billion - $1.74 Billion	25,095,789 New	25,095,789 $1.48 Billion

Others Institutions Holding BMY

# of Institutions

2,809

Shares Held

1.59B

Call Options Held

25.9M

Put Options Held

23.9M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $103B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account